112 related articles for article (PubMed ID: 35853900)
1. Patients with first-episode psychosis in northern Taiwan: neurocognitive performance and niacin response profile in comparison with schizophrenia patients of different familial loadings and relationship with clinical features.
Yu SC; Hwang TJ; Liu CM; Chan HY; Kuo CJ; Yang TT; Wang JP; Liu CC; Hsieh MH; Lin YT; Chien YL; Kuo PH; Shih YW; Yu SL; Chen HY; Chen WJ
BMC Psychiatry; 2024 Feb; 24(1):155. PubMed ID: 38389072
[TBL] [Abstract][Full Text] [Related]
2. Attenuated niacin response is associated with a subtype of first-episode drug-naïve psychosis characterized as serious negative symptoms.
Zhang T; Gan R; Zeng J; Ye J; Hu Y; Xu L; Wei Y; Tang X; Li C; Liu H; Chen T; Wang J
Eur Arch Psychiatry Clin Neurosci; 2023 Dec; 273(8):1725-1736. PubMed ID: 36688979
[TBL] [Abstract][Full Text] [Related]
3. Niacin skin flush and membrane polyunsaturated fatty acids in schizophrenia from the acute state to partial remission: a dynamic relationship.
Yu YH; Su HM; Lin SH; Hsiao PC; Lin YT; Liu CM; Hwang TJ; Hsieh MH; Liu CC; Chien YL; Kuo CJ; Hwu HG; Chen WJ
Schizophrenia (Heidelb); 2022 Apr; 8(1):38. PubMed ID: 35853900
[TBL] [Abstract][Full Text] [Related]
4. Phospholipid membrane abnormalities and reduced niacin skin flush response in schizophrenia.
Buretić-Tomljanović A; Giacometti J; Nadalin S; Rubesa G; Vulin M; Tomljanović D
Psychiatr Danub; 2008 Sep; 20(3):372-83. PubMed ID: 18827766
[TBL] [Abstract][Full Text] [Related]
5. Relationship between the niacin skin flush response and essential fatty acids in schizophrenia.
Messamore E
Prostaglandins Leukot Essent Fatty Acids; 2003 Dec; 69(6):413-9. PubMed ID: 14623495
[TBL] [Abstract][Full Text] [Related]
6. Niacin sensitivity and the arachidonic acid pathway in schizophrenia.
Messamore E; Hoffman WF; Yao JK
Schizophr Res; 2010 Sep; 122(1-3):248-56. PubMed ID: 20417059
[TBL] [Abstract][Full Text] [Related]
7. Niacin skin flush test: a research tool for studying schizophrenia.
Nadalin S; Buretić-Tomljanović A; Rubesa G; Tomljanović D; Gudelj L
Psychiatr Danub; 2010 Mar; 22(1):14-27. PubMed ID: 20305586
[TBL] [Abstract][Full Text] [Related]
8. The impact of PLA2G4A and PTGS2 gene polymorphisms, and red blood cell PUFAs deficit on niacin skin flush response in schizophrenia patients.
Nadalin S; Giacometti J; Jonovska S; Tomljanović D; Buretić-Tomljanović A
Prostaglandins Leukot Essent Fatty Acids; 2013 Feb; 88(2):185-90. PubMed ID: 23219238
[TBL] [Abstract][Full Text] [Related]
9. Associations between plasma fatty acid concentrations and schizophrenia: a two-sample Mendelian randomisation study.
Jones HJ; Borges MC; Carnegie R; Mongan D; Rogers PJ; Lewis SJ; Thompson AD; Zammit S
Lancet Psychiatry; 2021 Dec; 8(12):1062-1070. PubMed ID: 34735824
[TBL] [Abstract][Full Text] [Related]
10. A Systematic Review of Effectiveness of Omega-3 Fatty Acid Supplementation on Symptoms, Social Functions, and Neurobiological Variables in Schizophrenia.
Hsu MC; Ouyang WC
Biol Res Nurs; 2021 Oct; 23(4):723-737. PubMed ID: 34281415
[TBL] [Abstract][Full Text] [Related]
11. Increased PLA
Talib LL; Costa AC; Joaquim HPG; Pereira CAC; Van de Bilt MT; Loch AA; Gattaz WF
Eur Arch Psychiatry Clin Neurosci; 2021 Dec; 271(8):1593-1599. PubMed ID: 33677687
[TBL] [Abstract][Full Text] [Related]
12. An investigation of calcium-independent phospholipase A2 (iPLA2) and cytosolic phospholipase A2 (cPLA2) in schizophrenia.
Xu C; Yang X; Sun L; Yang T; Cai C; Wang P; Jiang J; Qing Y; Hu X; Wang D; Wang P; Cui G; Zhang J; Li Y; Ji F; Liu C; Wan C
Psychiatry Res; 2019 Mar; 273():782-787. PubMed ID: 31207866
[TBL] [Abstract][Full Text] [Related]
13. Oxidative Stress and Inflammation in First-Episode Psychosis: A Systematic Review and Meta-analysis.
Fraguas D; Díaz-Caneja CM; Ayora M; Hernández-Álvarez F; Rodríguez-Quiroga A; Recio S; Leza JC; Arango C
Schizophr Bull; 2019 Jun; 45(4):742-751. PubMed ID: 30169868
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
